Assessment of the CALLY Index, a Novel Immunonutrivite Marker, in Perioperatively Treated Gastric Cancer Patients
Gazi Medical Journal · 09.01.2025 · 36 (1) · 85-90
DOI: 10.12996/gmj.2024.4197 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gazi Medical Journal, online erschienen am 09.01.2025. Verfasst von Orhun Akdoğan und 4 weiteren Autor:innen. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Objective
This study aimed to investigate the prognostic significance of the C-reactive protein-albumin-lymphocyte (CALLY) index in patients with early-stage gastric cancer and compare it with other immune markers, such as systemic immune-inflammation index (SII), neutrophil lymphocyte ratio (NLR), and prognostic nutritional index (PNI).
Methods
We retrospectively analyzed patients with early-stage gastric cancer who received adjuvant or perioperative chemotherapy. Laboratory results were obtained from the preoperative period. The CALLY index was calculated as follows: serum albumin level (g/dL) x absolute lymphocyte counts (109/L) / CRP (mg/dL) x104.
Results
A total of 74 patients were included in the study. The median relapse-free survival (RFS) was 13.0 (95 %CI: 7.7-18.2) months in the low CALLY index group and 38.2 (95% CI:18.4-57.8) months in the high CALLY index group (p
Zitieren
APA
Akdoğan, O., Yücel, K. B., Yazıcı, O., Özet, A., & Özdemir, N. (2025). Assessment of the CALLY Index, a Novel Immunonutrivite Marker, in Perioperatively Treated Gastric Cancer Patients. Gazi Medical Journal, 36(1), 85-90. https://doi.org/10.12996/gmj.2024.4197
Vancouver
Akdoğan O, Yücel KB, Yazıcı O, Özet A, Özdemir N. Assessment of the CALLY Index, a Novel Immunonutrivite Marker, in Perioperatively Treated Gastric Cancer Patients. Gazi Medical Journal. 2025;36(1):85-90. doi:10.12996/gmj.2024.4197
BibTeX
@article{Akdoan2025,
author = {Akdoğan, Orhun and Yücel, Kadriye Bir and Yazıcı, Ozan and Özet, Ahmet and Özdemir, Nuriye},
title = {Assessment of the CALLY Index, a Novel Immunonutrivite Marker, in Perioperatively Treated Gastric Cancer Patients},
journal = {Gazi Medical Journal},
year = {2025},
volume = {36},
number = {1},
pages = {85--90},
doi = {10.12996/gmj.2024.4197}
}
EUVIMED